These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 34616392

  • 1. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD, Ferreira LMR, Ronin E, Ho P, Nguyen V, Faleo G, Zhou Y, Lee K, Leung KK, Skartsis N, Kaul AM, Mulder A, Claas FHJ, Wells JA, Bluestone JA, Tang Q.
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
    Dawson NA, Lamarche C, Hoeppli RE, Bergqvist P, Fung VC, McIver E, Huang Q, Gillies J, Speck M, Orban PC, Bush JW, Mojibian M, Levings MK.
    JCI Insight; 2019 Mar 21; 4(6):. PubMed ID: 30753169
    [Abstract] [Full Text] [Related]

  • 4. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q, Lu W, Liang CL, Chen Y, Liu H, Qiu F, Dai Z.
    Front Immunol; 2018 Mar 21; 9():2359. PubMed ID: 30369931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.
    Lamarthée B, Marchal A, Charbonnier S, Blein T, Leon J, Martin E, Rabaux L, Vogt K, Titeux M, Delville M, Vinçon H, Six E, Pallet N, Michonneau D, Anglicheau D, Legendre C, Taupin JL, Nemazanyy I, Sawitzki B, Latour S, Cavazzana M, André I, Zuber J.
    Nat Commun; 2021 Nov 08; 12(1):6446. PubMed ID: 34750385
    [Abstract] [Full Text] [Related]

  • 7. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets.
    Wu X, Chen PI, Whitener RL, MacDougall MS, Coykendall VMN, Yan H, Kim YB, Harper W, Pathak S, Iliopoulou BP, Hestor A, Saunders DC, Spears E, Sévigny J, Maahs DM, Basina M, Sharp SA, Gloyn AL, Powers AC, Kim SK, Jensen KP, Meyer EH.
    Front Immunol; 2024 Nov 08; 15():1415102. PubMed ID: 39007132
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
    Wagner JC, Ronin E, Ho P, Peng Y, Tang Q.
    Am J Transplant; 2022 Sep 08; 22(9):2237-2245. PubMed ID: 35434896
    [Abstract] [Full Text] [Related]

  • 12. Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy.
    Davari K, Holland T, Prassmayer L, Longinotti G, Ganley KP, Pechilis LJ, Diaconu I, Nambiar PR, Magee MS, Schendel DJ, Sommermeyer D, Ellinger C.
    J Immunother Cancer; 2021 Mar 08; 9(3):. PubMed ID: 33771892
    [Abstract] [Full Text] [Related]

  • 13. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
    Gille I, Claas FHJ, Haasnoot GW, Heemskerk MHM, Heidt S.
    Front Immunol; 2022 Mar 08; 13():874157. PubMed ID: 35720402
    [Abstract] [Full Text] [Related]

  • 14. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN, Erdes E, Hebeisen M, Rufer N.
    J Immunother Cancer; 2019 Nov 05; 7(1):284. PubMed ID: 31690351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD4+ T cells engineered with FVIII-CAR and murine Foxp3 suppress anti-factor VIII immune responses in hemophilia a mice.
    Fu RY, Chen AC, Lyle MJ, Chen CY, Liu CL, Miao CH.
    Cell Immunol; 2020 Dec 05; 358():104216. PubMed ID: 32987195
    [Abstract] [Full Text] [Related]

  • 17. Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo.
    He H, Vedia RA, Lu S, Li Q, Cox KR, St John L, Sergeeva A, Clise-Dwyer K, Alatrash G, Shpall EJ, Ma Q, Molldrem JJ.
    Cytotherapy; 2024 Nov 05; 26(11):1331-1340. PubMed ID: 39033444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.